Biotech receives award from DOD; Regulators accept Appili Therapeutics' NDA
EuMentis Therapeutics, a Boston-based biotech, has been handed an award from the US Department of Defense.
The $3 million award will be used by EuMentis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.